Cameron Gray is Director of Cue Biopharma, Inc.. Currently has a direct ownership of 687,049 shares of CUE, which is worth approximately $467,193. The most recent transaction as insider was on Jun 14, 2022, when has been sold 51,562 shares (Common Stock) at a price of $3.2 per share, resulting in proceeds of $164,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 687K
0% 3M change
0% 12M change
Total Value Held $467,193

Cameron Gray Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 14 2022
SELL
Payment of exercise price or tax liability
$164,998 $3.2 p/Share
51,562 Reduced 6.98%
687,049 Common Stock
Jun 14 2022
BUY
Exercise of in-the-money or at-the-money derivatives securities
$165,000 $2.7 p/Share
61,111 Added 7.64%
738,611 Common Stock
Sep 30 2020
BUY
Open market or private purchase
$76,500 $15.3 p/Share
5,000 Added 0.73%
677,500 Common Stock
Sep 29 2020
BUY
Open market or private purchase
$75,000 $15.0 p/Share
5,000 Added 0.74%
672,500 Common Stock
CG

Cameron Gray

Director
Cambridge, MA

Track Institutional and Insider Activities on CUE

Follow Cue Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CUE shares.

Notify only if

Insider Trading

Get notified when an Cue Biopharma, Inc. insider buys or sells CUE shares.

Notify only if

News

Receive news related to Cue Biopharma, Inc.

Track Activities on CUE